value-based care
The company was sold to an affiliate of New Enterprise Associates and a consortium of investors for $1.465 billion and ceased trading on the NYSE on Oct. 2.
The company claims the acquisition will strengthen its AI-enabled platform, improve care gap management and promote collaboration to advance value-based care.
The company will use the funds to expand its presence across the U.S. health market and enhance its AI technology and platform.
The company was acquired by an affiliate of New Enterprise Associates and a consortium of investors for $1.3 billion.
Healthcare investors Irem Rami and Sam Lesser discuss the unique challenges and opportunities associated with value-based care initiatives.
Matt Cybulsky, LBMC practice leader for healthcare AI, value-based care and product innovation, discusses paths to implement digital health tools for value-based care and the advantages of using AI to ease provider workflow.
The value-based care company will use the funds to enhance its datasets and services.
The companies will create a value-based care program to support cardiology patients and providers at health systems and CINs.
HIMSS24
Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.
HIMSS24
David Wolf, MedeAnalytics AVP, and Lynn Carroll, HSBlox COO, highlight value-based care models' crucial components, including contract modeling and performance measurement, and discuss change management for switching to these models.